Amanote Research
Register
Sign In
GITR Agonism Overcomes Resistance to Immunotherapy in Solid Tumors
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2019-070
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
May 10, 2019
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Advances in Cancer Immunotherapy in Solid Tumors
Cancers
Cancer Research
Oncology
Targeting C-Met Receptor Overcomes TRAIL-Resistance in Brain Tumors
PLoS ONE
Multidisciplinary
Editorial: Dendritic Cell-Based Immunotherapy in Solid and Haematologic Tumors
Frontiers in Immunology
Allergy
Immunology
Existing and Emerging Biomarkers for Immune Checkpoint Immunotherapy in Solid Tumors
Advances in Therapy
Medicine
Pharmacology
EZN-2208 (PEG-SN38) Overcomes ABCG2-Mediated Topotecan Resistance in BRCA1-Deficient Mouse Mammary Tumors
PLoS ONE
Multidisciplinary
A Naturally Generated Decoy of the Prostate Apoptosis Response-4 Protein Overcomes Therapy Resistance in Tumors
Cancer Research
Cancer Research
Oncology
Hurdles of CAR-T Cell-Based Cancer Immunotherapy Directed Against Solid Tumors
Science China Life Sciences
Genetics
Molecular Biology
Environmental Science
Biochemistry
Biological Sciences
Agricultural
TNFα Blockade Overcomes Resistance to Anti-Pd-1 in Experimental Melanoma
Nature Communications
Astronomy
Genetics
Molecular Biology
Biochemistry
Chemistry
Physics
Targeted and Untargeted CD137L Fusion Proteins for the Immunotherapy of Experimental Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology